Antagonism of vasoactive intestinal peptide mRNA in the suprachiasmatic nucleus disrupts the rhythm of FRAs expression in neuroendocrine dopaminergic neurons
- 16 July 2002
- journal article
- research article
- Published by Wiley in Journal of Comparative Neurology
- Vol. 450 (2), 135-143
- https://doi.org/10.1002/cne.10307
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Central Administration of Antiserum to Vasoactive Intestinal Peptide Delays and Reduces Luteinizing Hormone and Prolactin Surges in Ovariectomized, Estrogen-Treated RatsNeuroendocrinology, 1999
- Circadian change of dopaminergic neuron activityNeuroReport, 1997
- The cellular localization of vasoactive intestinal peptide (VIP) in the mouse median eminence by immuno-electron microscopyActa Histochemica, 1996
- Use of Fos-related antigens (FRAs) as markers of neuronal activity: FRA changes in dopamine neurons during proestrus, pregnancy and lactationBrain Research, 1994
- Median eminence-afferent vasoactive intestinal peptide (VIP) neurons in the hypothalamus: Localization by simultaneous tract tracing and immunocytochemistryPeptides, 1993
- Central Administration of Bombesin Blocks the Estrogen-Induced Afternoon Prolactin SurgeNeuroendocrinology, 1993
- Neuroendrocrine regulation of prolactin releaseProgress in Neurobiology, 1989
- Vasoactive intestinal peptide (VIP)-like immunoreactive neurons located in the rat suprachiasmatic nucleus receive a direct retinal projectionNeuroscience Letters, 1989
- Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphologyPeptides, 1986
- Vasoactive intestinal polypeptide (VIP) in mouse and rat brain: An immunocytochemical studyBrain Research, 1980